Smilow Cancer Hospital — New Haven, Connecticut

Smilow Cancer Hospital is a clinical research site located in New Haven, Connecticut, United States 06511.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Smilow Cancer Hospital has participated in 14 clinical trials with 7 currently active.

Therapeutic areas: Sickle Cell Disease, Transfusion-dependent Beta-Thalassemia, Hemoglobinopathies.

Sponsors: Editas Medicine, Inc., Incyte Corporation, Yale University.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Smilow Cancer Hospital?

Smilow Cancer Hospital has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Smilow Cancer Hospital conducted?

Smilow Cancer Hospital has 14 clinical trials on record, with 7 currently active. Their work covers Sickle Cell Disease, Transfusion-dependent Beta-Thalassemia, Hemoglobinopathies.

Is Smilow Cancer Hospital accredited by Crixeo Health?

Yes — Smilow Cancer Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Smilow Cancer Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.